Multiple Sclerosis Center Of Northeastern New York

Recent papers from Multiple Sclerosis Center Of Northeastern New York

1. Spinal cord imaging for multiple sclerosis: Advances, priorities, and opportunitiesMultiple Sclerosis Journal · 2026
2. Influence of Intonation on Auditory Sequential Memory SkillsPerceptual and Motor Skills · 1980
3. Autoimmune-associated epilepsy or acute symptomatic seizures? A case series of recurrent seizures in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)Epilepsy Research · 2026
4. Abstract PS5-04-26: Tailored Support for Young Women with Breast Cancer: Survey-Informed Program Development and Peer-Based InterventionClinical Cancer Research · 2026
5. Natalizumab and fumarate treatment differentially modulate CD4+ T cell and B cell subtypes in multiple sclerosis patients without impacting durable COVID-19 vaccine responsesFrontiers in Immunology · 2025
6. Guiding Multiple Sclerosis Care: An Update to the 2013 Consensus Statement from the MS in the 21st Century Steering GroupNeurology and Therapy · 2025
7. Persistent Classical and Atypical Memory B Cells Underlie Heterogeneous Vaccine Responses in Ocrelizumab-Treated Multiple Sclerosis2025
8. Transition from anti-CD20 therapies to fumarates as a treatment strategy: A multicenter, retrospective observational experienceMultiple Sclerosis Journal - Experimental Translational and Clinical · 2025
9. A multicenter cohort of transgender and gender diverse people with multiple sclerosisMultiple Sclerosis Journal · 2025
10. Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC RegistryJournal of Child Neurology · 2025
11. Letter on “Real‐World Clinical Experience With Serum MOG and AQP4 Antibody Testing by Live Versus Fixed Cell‐Based Assay”Annals of Clinical and Translational Neurology · 2025
12. Epigenetic Aging in Pediatric-Onset Multiple SclerosisNeurology · 2025
13. Comorbidities Are Associated With Unfavorable Outcome in Aquaporin‐4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease: Exploratory Study From the CROCTINO CohortEuropean Journal of Neurology · 2025
14. B cell-extrinsic and intrinsic factors linked to early immune repletion after anti-CD20 therapy in patients with Multiple Sclerosis of African Ancestry2025
15. Shared decision-making in underserved populations with multiple sclerosis: A systematic reviewMultiple Sclerosis and Related Disorders · 2024
16. Patterns of disease-modifying therapy utilization before, during, and after pregnancy and postpartum relapses in women with multiple sclerosisMultiple Sclerosis and Related Disorders · 2024
17. Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple SclerosisJAMA Neurology · 2024
18. Longitudinal study of immunity to SARS-CoV2 in Ocrelizumab-treated multiple sclerosis patients up to 2 years after COVID-19 vaccination2024
19. No Increase in Symptoms Toward the End of the Ocrelizumab Infusion Cycle in Patients With Multiple SclerosisNeurology Clinical Practice · 2023
20. Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: An observational study by the New York COVID-19 Neuro-Immunology Consortium (NYCNIC-2)Multiple Sclerosis Journal · 2023